HMG co-A reductase inhibitors statins

HMG Co-A reductase inhibitors (statins) have been shown to reduce the incidence of fatal and non-fatal myocardial infarction, stroke and mortality (all causes), as well as the need for coronary artery bypass surgery. Since no single drug has been shown to be significantly more effective or less expensive than others in the group, none is included in the model list the choice of drug for use in patients at highest risk should be decided at national level. 

The cholesterol-lowering agents 3-hydroxy-methyl-glutaryl Co-A reductase (HMG Co-A reductase) inhibitors (statins) have been demonstrated to reduce the risk... 

---